Clinical Trial Update: Blood Naloxone Levels Following Intradermal Injection in Humans [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating intradermal naloxone for opioid overdose has been withdrawn; no recruitment or results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Overdose

Drugs mentioned

• Naloxone (Naloxone)

Snippet

Sponsor: Johns Hopkins University | Conditions: Opioid Overdose | Phase 4 | Status: WITHDRAWN